Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Hormones – e.g. – prolactin – thymosin – growth factors – etc.
Patent
1995-06-05
1998-11-10
Ulm, John
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Hormones, e.g., prolactin, thymosin, growth factors, etc.
930120, 514 12, C07K 1461, A61K 3827
Patent
active
058345981
ABSTRACT:
A method for selecting novel proteins such as growth hormone and antibody fragment variants having altered binding properties for their respective receptor molecules is provided. The method comprises fusing a gene encoding a protein of interest to the carboxy terminal domain of the gene III coat protein of the filamentous phage M13. The gene fusion is mutated to form a library of structurally related fusion proteins that are expressed in low quantity on the surface of a phagemid particle. Biological selection and screening are employed to identify novel ligands useful as drug candidates. Disclosed are preferred phagemid expression vectors and selected human growth hormone variants.
REFERENCES:
patent: 4593002 (1986-06-01), Dulbecco
patent: 5223409 (1993-06-01), Ladner et al.
patent: 5534617 (1996-07-01), Cunningham et al.
Binder et al. Site-directed mutations of human growth hormone that selectively modify its lactogenic activity and binding properties. Molecular Endocrinology. vol. 4, No. 7, p. 1060, Jul. 1990.
Nishikawa et al. Structure and activity of artificial mutant variants of human growth hormone. Protein Engineering. vol. 3, No. 1, p. 49, Oct. 1989.
Lehninger. Biochemistry, 2d ed. Worth Publishers, Inc., New York, NY. Figures 4.2-4.4. 1975.
Armstrong et al., "Domain Structure of Bacteriophage fd Adsorption Protein" FEBS Letters 135(1):167-172 (1981).
Bass et al., "Hormone Phage: An Enrichment Method for Variant Proteins with Altered Binding Properties" Proteins: Structure, Function, and Genetics 8(4):309-314 (1990).
Bowie et al., "Deciphering the Message in Protein Sequences: Tolerance to Amino Acid Substitutions" Science 247:1306-1310 (1990).
Crissman et al., "Gene-III protein of filamentous phages: evidence for a carboxyl-terminal domain with a role in morphogenesis" Virology 132(2):445-455 (1984).
Cunningham et al., "Engineering human prolactin to bind to the human growth hormone receptor" Science 247:1461-1465 (1990).
Cwirla et al., "Peptides on phage: a vast library of peptides for identifying ligands" Proc. Natl. Acad Sci. USA 87(16):6378-6382 (1990).
De la Cruz et al., "Immunogenicity and epitope mapping of foreign sequences via genetically engineered filamentous phage" Journal of Biological Chemistry 263 (9):4318-4322 (1988).
Devlin et al., "Random peptide libraries: a source of specific protein binding molecules" Science 249:404-406 (1990).
Fuh et al., "The human growth hormone receptor. Secretion from Escherichia coli and disulfide bonding pattern of the extracellular binding domain" Journal of Biological Chemistry 265(6):3111-3115 (1990).
Geysen, "Antigen -antibody interactions at the molecular level: adventures in peptide synthesis" Immunology Today 6:364-369 (1985).
Geysen et al., "A priori delineation of a peptide which mimics a discontinuous antigenic determinant" Molecular Immunology 23(7):709-715 (1986).
Gussow et al., "Generating Binding Activities from Escherichia coli by Expression of a Repertoire of Immunoglobulin Variable Domains" Cold Spring Harbor Symposia on Quantitative Biology 54:265-272 (1989).
Lowman et al., "Selecting High-Affinity Binding Proteins by Monovalent Phage Display" Biochemistry 30:10832-10838 (1991).
McCafferty et al., "Phage antibodies: filamentous phage displaying antibody variable domains" Nature 348:552-554 (1990).
McFarland et al., "Lutropin-Choriogonadotropin Receptor: An Unusual Member of the G Protein-Coupled Receptor Family" Science 245:494-499 (1989).
Orlandi et al., "Cloning Immunoglobulin Variable Domains for Expression by the Polymerase Chain Reaction" Proc. Natl. Acad. Sci. USA 86:3833-3837 (1989).
Parmley et al., "Antibody-selectable filamentous fd phage vectors: affinity purification of target genes" Gene 73:305-318 (1988).
Queen et al., "A humanized antibody that binds to the interleukin 2 receptor" Proc. Natl. Acad. Sci. USA 86(24):10029-10033 (Dec. 1989).
Rasched et al., "Ff coliphages: structural and functional relationships" Microbiol. Rev. 50(4):401-427 (1986).
Roberts et al., "Directed evolution of a protein: Selection of potent neutrophil elastase inhibitors displayed on M13 fusion phage" Proc. Natl. Acad. Sci USA 89:2429-2433 (1992).
Rutter et al., "Redesigning Proteins via Genetic Engineering" Protein Engineering, Oxender & Fox, Chapter 23, pp. 257-267 (1987).
Scott et al., "Searching for peptide ligands with an epitope library" Science 249:386-390 (1990).
Shortle,, "Genetic Strategies for Analyzing Proteins" Protein Engineering, Oxender & Fox (eds.), New York:A.R. Liss, Inc. pp. 103-108 (1985).
Smith, "Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface" Science 228(4705):1315-1317 (1985).
Wells, "Additivity of Mutational Effects in Proteins" Biochemistry 29:8509-8517 (1990).
Wells et al., "Cassette Mutagenesis: an Efficient Method for Generation of Multiple Mutations at Defined Sties" Gene 34(2-3):315-323 (1985).
Lowman Henry B.
Wells James A.
Genentech Inc.
Saovd Christine
Schwartz Timothy R.
Ulm John
Winter Daryl B.
LandOfFree
Human growth hormone variants does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human growth hormone variants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human growth hormone variants will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1517877